PhlebitisNCT07051798
Phlebitis Experiences of Intensive Care Nurses
An observational study of Phlebitis and NursİNG CARE, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
Trial summary
It is important to reveal the phlebitis experiences of nurses. The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Phlebitis, NursİNG CARE
- What is being tested?
- It is a qualitative type of study that will be conducted through face-to-face interviews.
- How many people
- 20 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Jul 2025to 15 Mar 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Intensive Care nurses
Who may be able to join
- Voluntarily accepting to participate in the study
- Being the primary nurse of a patient who developed phlebitis,
- Having at least 1 year of work experience.
Who cannot join
- Being assigned to the unit for a short period of time
- Being on leave or sick leave,
- Not accepting to participate in the study,
- Leaving the study during the data collection process.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kutahya Health Sciences University
Kütahya, Kütahya, 43000
About this study
Official title: Phlebitis Experiences of Intensive Care Nurses: A Qualitative Study
It is important to reveal the phlebitis experiences of nurses. The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices. In the studies conducted to date, no study has been found in the literature that qualitatively examines the phlebitis experiences of intensive care nurses. This study is the first to be conducted in this respect, which constitutes the originality of the research. It is expected to guide clinician and academic nurses in phlebitis assessment and phlebitis care planning and to contribute to the literature.
- Conditions
- Phlebitis, NursİNG CARE
- Being tested
- It is a qualitative type of study that will be conducted through face-to-face interviews.
- Medical subject headings
- Phlebitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
It is a qualitative type of study that will be conducted through face-to-face interviews.Other
It is a qualitative type of study that will be conducted through face-to-face interviews.
What is being measured
The primary outcome is the main question the study is designed to answer.
Themes Identified in ICU Nurses' Experiences with Phlebitis Management
Identification of distinct thematic categories from ICU nurses' experiences concerning the recognition, prevention, care practices, and clinical challenges related to phlebitis. Each theme will be extracted through thematic analysis of qualitative data obtained from semi-structured interviews. Method of Analysis: Braun \& Clarke's Thematic Analysis Method Unit of Measure: Number of distinct themes identified
Measured: Within the first 2 months following the initiation of the study
Perceived Barriers and Facilitators in Phlebitis Management
Evaluation and classification of ICU nurses' perceptions regarding institutional, educational, and individual-level factors affecting phlebitis assessment and management. Each perceived barrier or facilitator will be categorized based on content analysis of semi-structured interview transcripts. Method of Analysis: Content Analysis Methodology Unit of Measure: Number of identified barriers and facilitators.
Measured: Within 2 month after the completion of data collection
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jul 2025
- Study start15 Jul 2025
- Primary completion15 Aug 2025
- Study completion15 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PhlebitisStudies of the same condition, open and under way.
- More trials run by Kutahya Health Sciences UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kutahya Health Sciences University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07051798
- Sponsor's protocol ID
- KHSU20250607
- Status last verified
- Jun 2025
- First submitted
- 12 Jun 2025
- Last updated
- 20 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Phlebitis Experiences of Intensive Care Nurses: A Qualitative Study
- ClinicalTrials.gov ID
- NCT07051798
- Acronym / sponsor ID
- KHSU20250607
- Conditions
- Phlebitis, NursİNG CARE
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Kutahya Health Sciences UniversityUniversity, hospital or other
- Study start
- 15 Jul 2025 (actual)
- Primary completion
- 15 Aug 2025 (actual)
- Study completion
- 15 Mar 2026 (actual)
- First posted
- 4 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
It is important to reveal the phlebitis experiences of nurses. The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices. In the studies conducted to date, no study has been found in the literature that qualitatively examines the phlebitis experiences of intensive care nurses. This study is the first to be conducted in this respect, which constitutes the originality of the research. It is expected to guide clinician and academic nurses in phlebitis assessment and phlebitis care planning and to contribute to the literature.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Intensive Care nurses
Key inclusion criteria (3 listed)
- Voluntarily accepting to participate in the study
- Being the primary nurse of a patient who developed phlebitis,
- Having at least 1 year of work experience.
Key exclusion criteria (4 listed)
- Being assigned to the unit for a short period of time
- Being on leave or sick leave,
- Not accepting to participate in the study,
- Leaving the study during the data collection process.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| It is a qualitative type of study that will be conducted through face-to-face interviews.It is a qualitative type of study that will be conducted through face-to-face interviews. | Other | – |
Primary outcome
Themes Identified in ICU Nurses' Experiences with Phlebitis Management
Time frame: Within the first 2 months following the initiation of the study
Identification of distinct thematic categories from ICU nurses' experiences concerning the recognition, prevention, care practices, and clinical challenges related to phlebitis. Each theme will be extracted through thematic analysis of qualitative data obtained from semi-structured interviews. Method of Analysis: Braun \& Clarke's Thematic Analysis Method Unit of Measure: Number of distinct themes identified
Perceived Barriers and Facilitators in Phlebitis Management
Time frame: Within 2 month after the completion of data collection
Evaluation and classification of ICU nurses' perceptions regarding institutional, educational, and individual-level factors affecting phlebitis assessment and management. Each perceived barrier or facilitator will be categorized based on content analysis of semi-structured interview transcripts. Method of Analysis: Content Analysis Methodology Unit of Measure: Number of identified barriers and facilitators.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Phlebitis
Recruiting
Evaluation of Proximal Massage and Palm-to-Fist Tapping on Reducing the Risk of Phlebitis
Phlebitis, Catheter Complications
Not yet recruitingObservational study
Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Patient Safety and Quality of Intravascular Access Devices Care Management - The Safe-IVADs Project. A Longitudinell Implementation Intervention With an Embedded Process Evaluation.
Phlebitis, Thrombophlebitis
Recruiting
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
Not yet recruitingPhase 2
Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel
Cancer, Chemotherapy
Not yet recruiting
Prevention of Phlebitis, Infiltration and Extravasation With Infusion Monitoring System
Extravasation, Intensive Care Units (ICUs)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Phlebitis and NursİNG CARE, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Themes Identified in ICU Nurses' Experiences with Phlebitis Management (time frame: Within the first 2 months following the initiation of the study). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.